查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2083857

臍帶血庫市場：2026-2032年全球市場預測（依血庫模式、服務類型、應用領域及最終用戶分類）

Umbilical Cord Blood Banking Market by Banking Model, Offerings, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，臍帶血庫市場規模將達到 1,194.4 億美元，年複合成長率為 17.54%。

主要市場統計數據
基準年 2025 385.2億美元
預計年份：2026年 448.6億美元
預測年份 2032 1194.4億美元
複合年成長率 (%) 17.54%

臍帶血庫儲存出生後採集的造血幹細胞和前驅細胞，以備將來用於同種異體或自體移植。自1988年首例臍帶血移植成功以來，臍帶血已成為某些血液癌症、骨髓衰竭症候群、遺傳性免疫力缺乏缺陷疾病、血紅蛋白疾病和代謝性疾病的造血幹細胞移植的成熟來源。

新生兒幹細胞保存意識的不斷提高、公共臍帶血庫的擴充、對私人家庭臍帶血庫的持續需求，以及美國FDA、AABB、FACT和NetCord等監管機構和認證組織日益嚴格的品質標準，共同推動了這一行業的發展。消費者和臨床實務對「臍帶血庫」、「幹細胞保存」、「新生兒幹細胞」、「臍帶血移植」和「造血幹細胞庫」等關鍵字的搜尋需求持續旺盛。

臍帶血庫產業的變革性變化

臍帶血庫產業正從基礎冷凍保存轉型為基於實證醫學的細胞治療基礎設施。公共臍帶血庫對於確保獲得非親緣供者至關重要，尤其對於那些沒有合適成年供者的患者而言；而私人臍帶血庫則透過透明的定價、附加服務、臍帶組織共同保存、數位化家庭健康門戶以及樣本的長期可追溯性來凸顯自身優勢。

人工智慧（AI）的累積影響

人工智慧（AI）正逐漸成為臍帶血庫切實可行的營運基礎。 AI驅動的分析可以幫助匹配供體和受體，預測細胞活力趨勢，最佳化採集物流，檢測低溫儲存期間的溫度偏差，提高公共登記機構的庫存利用率，並加強品管系統的文件記錄。

對關鍵區域的洞察

北美臍帶血庫市場依然成熟，這得益於FDA的監管、AABB和FACT的認證、完善的移植網路、參與公共登記系統以及美國和加拿大消費者較高的意識。歐洲則受益於公共血庫基礎設施、基於GDPR的資料保護以及基於歐洲標準的統一組織和細胞品質框架。同時，在中東，尤其是在海灣合作理事會（GCC）市場，家庭血庫正透過私人醫療投資、醫療旅遊以及專業的母嬰護理服務不斷發展壯大。

關鍵區域洞察

在東協市場，受都市化、私人產科醫療、醫療旅遊和中產階級壯大的推動，人們對新生兒幹細胞保存的認知日益提高，並受到廣泛關注。海灣合作理事會（GCC）國家正加大對高階家庭保存服務、醫院現代化和先進醫療基礎設施的投資。同時，歐盟為組織可追溯性、捐贈者知情同意、品質保證、資料保護以及人類細胞和組織的跨境監管提供了最嚴格的法規環境之一。

主要國家的概況

美國在市場成熟度、FDA監管的臍帶血製品、與公共登記機構的合作以及其強大的移植網路方面處於主導地位。而加拿大則強調與公共衛生部門的合作、認證的臍帶血庫以及公平取得捐贈者的途徑。墨西哥和巴西正在擴大私人臍帶血庫規模，同時提升移植能力，其中巴西受益於其完善的醫療基礎設施以及在整個拉丁美洲積累的造血幹細胞移植經驗。

為行業領導者提供的實用建議

行業領導者應優先考慮臨床可信度，並按照已通過核准且有循證依據的用途推廣臍帶血。清晰的知情同意、透明的儲存費用、檢驗的處理方法、完善的儲存歷史記錄、傳染病篩檢以及權威機構的認證，都能增強父母、臨床醫生、監管機構和支付方的信任。

調查方法

本執行摘要基於來自權威資訊來源的關於醫療保健、移植、監管和認證的二手研究。這些研究包括FDA關於人類細胞和組織的指南、AABB和FACT標準、NetCord的營運實務、公開註冊資訊以及關於造血幹細胞移植和臍帶血庫的同行評審文獻。

結論

臍帶血庫正從單純的消費者儲存服務發展成為數據驅動型細胞治療生態系統中受監管的組成部分。這種需求的促進因素包括：成熟的移植應用、父母意識的提高、以品質為中心的認證體系，以及不斷進行的旨在提高幹細胞效用和移植效果的研究。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：臍帶血庫市場：依血庫模式分類

  • 私人的
  • 民眾

第8章：臍帶血庫市場：依服務類型分類

  • 收藏
  • 過程
    • 細胞分離
    • 存活率檢驗
    • 產能下降
  • 發布
  • 貯存

第9章：臍帶血庫市場：依應用領域分類

  • 血液疾病
    • 貧血
    • 白血病
    • 淋巴瘤
  • 免疫疾病
  • 代謝性疾病
  • 再生醫學
  • 調查

第10章：臍帶血庫市場：依最終用戶分類

  • 診斷檢查室
  • 醫院和診所
  • 研究機構

第11章：臍帶血庫市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：臍帶血庫市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 臍帶血庫市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Banco de Cordon Umbilical SL
  • Canadian Blood Services
  • Cell Care Pty Ltd
  • Cells4Life Group LLP
  • Cord Blood Registry, LLC
  • Cordvida Ltda
  • Cryo-Cell International, Inc.
  • CryoCenter SA
  • CryoHoldco LLC
  • Future Health Biobank Ltd
  • Global Cord Blood Corporation
  • LifeCell International Private Limited
  • Lifeforce Cryobanks Pvt Ltd
  • Macopharma SA
  • Medipost Co., Ltd.
  • National Cord Blood Program
  • NeoStem Inc.
  • PBKM FamiCord Group
  • Redcord SA
  • Singapore Cord Blood Bank
  • Smart Cells International Ltd.
  • StemCyte, Inc.
  • Stemlife Berhad
  • ViaCord, LLC
  • Virgin Life Sciences Ltd
  • Vita 34 AG
Product Code: MRR-430D5F382283

The Umbilical Cord Blood Banking Market is projected to grow by USD 119.44 billion at a CAGR of 17.54% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 38.52 billion
Estimated Year [2026] USD 44.86 billion
Forecast Year [2032] USD 119.44 billion
CAGR (%) 17.54%

Umbilical cord blood banking preserves hematopoietic stem and progenitor cells collected after birth for potential use in allogeneic or autologous transplantation. Since the first successful cord blood transplant in 1988, cord blood has become an established source for hematopoietic stem cell transplantation in selected blood cancers, marrow failure syndromes, inherited immune deficiencies, hemoglobinopathies, and metabolic disorders.

The industry is shaped by rising awareness of newborn stem cell preservation, expanding public cord blood registries, continued private family banking demand, and stricter quality standards from regulators and accreditation bodies such as the U.S. FDA, AABB, FACT, and NetCord. Search demand around cord blood banking, stem cell storage, newborn stem cells, cord blood transplant, and hematopoietic stem cell banking continues to reflect strong consumer and clinical interest.

Transformative Shifts in the Cord Blood Banking Landscape

The cord blood banking landscape is shifting from basic cryogenic storage toward evidence-driven cellular therapy infrastructure. Public banks remain essential for unrelated donor access, especially for patients who lack matched adult donors, while private banks increasingly differentiate through transparent pricing, genetic testing add-ons, dual cord tissue storage, digital family health portals, and long-term sample traceability.

Clinical demand is also evolving as transplant centers refine HLA matching, cell dose selection, double-unit transplantation strategies, and ex vivo expansion approaches designed to address the historically lower cell dose in cord blood units. At the same time, regulatory scrutiny over unproven regenerative claims is increasing, requiring participants to clearly separate established transplant indications from investigational applications in neurology, diabetes, cardiovascular repair, and tissue regeneration.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical operating layer for cord blood banks. AI-enabled analytics can support donor-recipient matching, predict cell viability trends, optimize collection logistics, flag temperature deviations in cryogenic storage, improve inventory utilization across public registries, and strengthen documentation for quality management systems.

The cumulative impact is strongest where AI is paired with validated laboratory data, electronic medical records, high-integrity chain-of-custody systems, and compliant consent workflows. However, AI adoption must align with data privacy laws, explainability expectations, clinical governance, and cybersecurity controls because cord blood banking decisions affect transplant eligibility, long-term storage integrity, regulatory compliance, and family trust.

Key Regional Insights

North America remains a mature cord blood banking region, supported by FDA oversight, AABB and FACT accreditation, established transplant networks, public registry participation, and strong consumer awareness in the United States and Canada. Europe benefits from public banking infrastructure, GDPR-driven data protections, and harmonized tissue and cell quality frameworks under European standards, while the Middle East is expanding family banking through private healthcare investment, medical tourism, and specialized maternal and neonatal care, particularly across GCC markets.

Asia-Pacific shows high long-term potential due to large birth cohorts, rising healthcare spending, expanding stem cell research, and improving biobanking infrastructure in China, India, Japan, South Korea, and Australia. Latin America is advancing through Brazil and Mexico, where transplant capacity, private maternity care, and cord blood banking awareness are improving. Africa remains underpenetrated, with opportunities tied to maternal health access, laboratory investment, cold-chain reliability, clinician education, and regional public-private partnerships that can support equitable access to newborn stem cell preservation.

Key Group Insights

ASEAN markets are gaining attention as urbanization, private maternity care, medical tourism, and expanding middle-income populations increase awareness of newborn stem cell storage. GCC countries are investing in premium family banking, hospital modernization, and advanced healthcare infrastructure, while the European Union provides one of the strongest regulatory environments for tissue traceability, donor consent, quality assurance, data protection, and cross-border oversight of human cells and tissues.

BRICS countries combine large birth populations with expanding biotechnology capacity, making them important for long-term cord blood banking development and clinical research participation. G7 countries lead in transplant standards, accredited laboratory practices, registry integration, and evidence-based clinical governance. NATO member countries, while not a healthcare bloc, generally benefit from resilient medical infrastructure, established biobanking practices, emergency preparedness systems, and cross-border research collaboration that can support quality-focused cord blood banking ecosystems.

Key Country Insights

The United States leads in commercial maturity, FDA-regulated cord blood products, public registry integration, and transplant network depth, while Canada emphasizes public health integration, accredited banking, and equitable donor access. Mexico and Brazil are expanding private banking alongside improving transplant capacity, with Brazil supported by a broad healthcare base and experience in hematopoietic stem cell transplantation across Latin America.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong clinical governance, public banking foundations, tissue and cell quality standards, and established transplant expertise, while Russia has domestic biobanking and transplant activity shaped by national regulation. China and India offer scale through high birth volumes, biotechnology investment, and growing hospital-based awareness; Japan, Australia, and South Korea contribute advanced clinical research, quality systems, digital health adoption, and sophisticated healthcare infrastructure that support evidence-led cord blood banking practices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical credibility by aligning marketing with approved and evidence-based uses of cord blood. Clear consent, transparent storage fees, validated processing methods, robust chain-of-custody documentation, infectious disease screening, and accreditation from recognized bodies improve trust among parents, clinicians, regulators, and payers.

Banks should invest in interoperable digital records, AI-supported quality monitoring, cryogenic risk controls, and partnerships with hospitals, obstetricians, midwives, transplant centers, and public registries. Growth strategies should balance private banking revenue with public health value, especially in ethnically diverse populations where matched donor access remains a documented challenge and cord blood can provide greater HLA-matching flexibility.

Research Methodology

The executive summary is based on secondary research from recognized healthcare, transplant, regulatory, and accreditation sources, including FDA guidance for human cells and tissues, AABB and FACT standards, NetCord practices, public registry information, and peer-reviewed literature on hematopoietic stem cell transplantation and cord blood banking.

The analysis evaluates industry drivers, regulatory conditions, regional healthcare infrastructure, technology adoption, quality standards, and clinical evidence. Insights were cross-checked for consistency with established cord blood banking practices and excluded unsupported claims about unapproved regenerative therapies, market sizing, market share, and market forecasting.

Conclusion

Umbilical cord blood banking is moving from a consumer storage service toward a regulated, data-enabled component of cellular therapy ecosystems. Demand is supported by established transplant use, increasing parental awareness, quality-focused accreditation, and ongoing research into ways to improve stem cell utility and transplant outcomes.

Future competitiveness will depend on quality, compliance, transparency, ethical communication, and responsible innovation. Organizations that combine accredited processing, evidence-based education, AI-enabled operations, secure data governance, and strong clinical partnerships will be best positioned in the global cord blood banking industry.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Umbilical Cord Blood Banking Market, by Banking Model

  • 7.1. Private
  • 7.2. Public

8. Umbilical Cord Blood Banking Market, by Offerings

  • 8.1. Collection
  • 8.2. Processing
    • 8.2.1. Cell Separation
    • 8.2.2. Viability Testing
    • 8.2.3. Volume Reduction
  • 8.3. Release
  • 8.4. Storage

9. Umbilical Cord Blood Banking Market, by Application

  • 9.1. Blood Disorders
    • 9.1.1. Anemia
    • 9.1.2. Leukemia
    • 9.1.3. Lymphoma
  • 9.2. Immune Disorders
  • 9.3. Metabolic Disorders
  • 9.4. Regenerative Medicine
  • 9.5. Research

10. Umbilical Cord Blood Banking Market, by End User

  • 10.1. Diagnostic Laboratories
  • 10.2. Hospitals & Clinics
  • 10.3. Research Institutes

11. Umbilical Cord Blood Banking Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Umbilical Cord Blood Banking Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Umbilical Cord Blood Banking Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Banco de Cordon Umbilical S.L.
  • 15.2. Canadian Blood Services
  • 15.3. Cell Care Pty Ltd
  • 15.4. Cells4Life Group LLP
  • 15.5. Cord Blood Registry, LLC
  • 15.6. Cordvida Ltda
  • 15.7. Cryo-Cell International, Inc.
  • 15.8. CryoCenter S.A.
  • 15.9. CryoHoldco LLC
  • 15.10. Future Health Biobank Ltd
  • 15.11. Global Cord Blood Corporation
  • 15.12. LifeCell International Private Limited
  • 15.13. Lifeforce Cryobanks Pvt Ltd
  • 15.14. Macopharma S.A.
  • 15.15. Medipost Co., Ltd.
  • 15.16. National Cord Blood Program
  • 15.17. NeoStem Inc.
  • 15.18. PBKM FamiCord Group
  • 15.19. Redcord S.A.
  • 15.20. Singapore Cord Blood Bank
  • 15.21. Smart Cells International Ltd.
  • 15.22. StemCyte, Inc.
  • 15.23. Stemlife Berhad
  • 15.24. ViaCord, LLC
  • 15.25. Virgin Life Sciences Ltd
  • 15.26. Vita 34 AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PUBLIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PUBLIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PUBLIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CELL SEPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CELL SEPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CELL SEPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VIABILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VIABILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VIABILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VOLUME REDUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VOLUME REDUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VOLUME REDUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RELEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RELEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RELEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL STORAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STORAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STORAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANEMIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANEMIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANEMIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LEUKEMIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LEUKEMIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LEUKEMIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LYMPHOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LYMPHOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LYMPHOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IMMUNE DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMMUNE DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IMMUNE DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 119. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 120. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 121. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 123. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 140. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 141. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 142. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 144. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 147. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 148. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 149. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 151. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 162. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 163. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 164. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 166. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 169. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 170. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 171. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 173. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 176. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 177. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 178. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 180. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 190. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 191. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 192. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 194. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 197. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 198. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 199. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 201. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 204. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 205. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 206. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 208. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 211. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 212. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 213. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 215. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 218. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 219. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 220. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 222. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 232. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 233. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 234. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 236. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 239. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 240. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 241. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 243. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 246. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 247. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 248. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 250. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2032 (USD MILLION)
  • TABLE 253. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 254. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2032 (USD MILLION)
  • TABLE 255. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 257. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)